Advanced Filters
noise
Found 1,204 clinical trials

How to Reduce Suicidal Thoughts and Impulsivity in Depression

The study aims at investigating if tDCS applied to left DLPFC or to right OFC to treatment as usual is effective in reducing severe suicidal ideas in major depressive episode.

18 years of age All Phase N/A
B Brenna R Renn, PhD

Engage for Late-Life Depression and Comorbid Executive Dysfunction

Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies. Engage is …

60 years of age All Phase N/A
S Sara Tremblay, PhD

Comparing Uni- and Bi-lateral TBS in Major Depression

Repetitive transcranial magnetic stimulation (rTMS) is a Health Canada approved treatment for major depression. Theta burst stimulation (TBS) is a very promising new treatment for major depression that allows a 15-fold reduction in duration of daily sessions. However, no large scale naturalistic study has assessed the superiority of bilateral TBS …

18 years of age All Phase N/A
M Monique van Velzen, PhD

Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists

In this pharmacokinetic/pharmacodynamic modelling study we will determine the ability of intranasal and intramuscular naloxone to reverse opioid (fentanyl and sufentanil)- induced respiratory depression in healthy volunteers and chronic opioid users to develop dosing recommendations in case of opioid-induced respiratory depression from an opioid overdose in clinical practice and in …

18 - 70 years of age All Phase 1
S Susie Andersen

Schema Therapy for Patients With Chronic Treatment Resistant Depression

The goal of this clinical study is to test a particular form of psychotherapy, called schema therapy, for people with difficult-to-treat depression (when depression is very lengthy or difficult to cure with antidepressive medication). Researchers will compare the group of participants receiving schema therapy to a group receiving standard psychotherapeutic …

18 - 65 years of age All Phase N/A

Stellate Ganglion Block for Prevention of Post Mastectomy Depression

Complications after mastectomy include chronic pain and depression.

21 - 65 years of age Female Phase N/A
a aNUSHA Basakran, PhD

Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression

The goal of this clinical trial is to evaluate the safety and initial effectiveness of Magnetic Resonance-guided focused ultrasound neuromodulation using the Next Generation Dome Helmet (NGDH) device in patients with treatment-resistant depression. This is a prospective, single-arm, non-randomized study. Participants will: Undergo two focused ultrasound treatment sessions targeting nodes …

18 - 65 years of age All Phase N/A
B BEYAZIT GARİP, Medical Doctor

Molecular Signatures of TMS Response in Treatment-Resistant Depression

Transcranial Magnetic Stimulation (TMS) therapy is an approved and effective treatment option for treatment-resistant depression (TRD). This study aims to identify biomarkers that predict TMS treatment response in TRD, provide insights into the neurobiological mechanisms underlying TMS efficacy, and contribute to personalized treatment strategies. By establishing proteomic and metabolomic signatures, …

18 - 65 years of age All Phase N/A
M Meikun Wang, MD

The Association Between Gut Microbiota Diversity and Postpartum Depression

This study aims to examine whether naturally occurring bacteria in the gastrointestinal tract are associated with mood changes following childbirth, including postpartum depression. Biological samples will be collected before and after delivery to determine whether specific patterns in gut bacterial composition are linked to emotional states. The purpose of the …

18 years of age Female Phase N/A
A Alec P Shannon, B.S.

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

We propose to test the hypothesis that bezafibrate, a pan-PPAR agonist, may be effective and safe for bipolar depression with the following specific aims: Aim #1. Proof-of-Concept Safety and Tolerability Aim: To assess the safety and tolerability of bezafibrate added to anti-manic medication for bipolar depression, especially with regard to …

18 - 65 years of age All Phase 2

Simplify language using AI